Publications

Recent Approvals of Medicines Containing a New Active Ingredient

This article is more than five years old. Some content may no longer be current.

Prescriber Update 39(2): 29
June 2018

For the period 16 January 2018 to 15 April 2018.

Trade Name (active ingredient)	Dose Form and Strength	Therapeutic Area
Movantik (naloxegol oxalate)	Film coated tablet 12.5 mg and 25 mg	Opioid-induced constipation
Zurampic (lesinurad)	Film coated tablet 200 mg	Gout

See the Medsafe website for data sheets of currently marketed medicines (www.medsafe.govt.nz/Medicines/infoSearch.asp).